KRAS and colorectal cancer: Liu et al. found a correlation between intratumor metabolic heterogeneity parameters of 18F-FDG PET/CT and KRAS mutation status in colorectal cancer – KRAS mutant tumors had more 18F-FDG uptake and heterogeneity than wild-type KRAS (Liu et al., 2022a).